Crinetics Pharmaceuticals, Inc. (CRNX) Financials
Key financial figures for Crinetics Pharmaceuticals, Inc. (Q1 2026).
- Revenue
- $11M
- Net Income
- -$128M
- EPS
- $-1.23
- Total Assets
- $1.4B
- Operating Cash Flow
- -$125M
Full income statement, balance sheet, and cash flow for Crinetics Pharmaceuticals, Inc. on SentiSense.